Earnings History Data for Omeros Corporation (OMER) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Omeros Corporation
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2024 | AH | OMER | Omeros Corporation | 248.59 | -0.64 | 0.00 | -0.82 | Omeros up 4% as Q3 results beat on EPS [11/13/2024 5:19 PM] |
6.83 | 2.64 (63.01%) |
4.20 | 0.01 (0.24%) |
1.38 - 7.51 | 13,872,225 | 300,000 | 6,630 | ||
| 07-08-2024 | AH | OMER | Omeros Corporation | 253.22 | -1.12 | 0.00 | -0.70 | Omeros GAAP EPS of -$0.97 misses by $0.02 [8/7/2024 4:37 PM] |
3.92 | -0.23 (-5.54%) |
4.05 | -0.10 (-2.41%) |
0.92 - 5.68 | 780,292 | 500,000 | 27,654 | ||
| 15-05-2024 | AH | OMER | Omeros Corporation | 203.38 | -0.74 | -0.61 | -0.63 | Omeros GAAP EPS of -$0.63 misses by $0.07 [5/15/2024 4:05 PM] |
3.31 | -0.86 (-20.74%) |
3.69 | -0.48 (-11.51%) |
0.92 - 7.80 | 1,150,867 | 240,000 | 1,270 | ||
| 01-04-2024 | AH | OMER | Omeros Corporation | 215.00 | -0.63 | 0.00 | -0.73 | Omeros GAAP EPS of -$0.63 misses by $0.07 [4/1/2024 4:05 PM] |
3.04 | -0.15 (-4.70%) |
3.20 | 0.01 (0.31%) |
0.92 - 7.80 | 1,053,324 | 350,000 | 7,831 | ||
| 09-11-2023 | AH | OMER | Omeros Corporation | 89.26 | -0.82 | -0.62 | -0.87 | Omeros GAAP EPS of -$0.82 misses by $0.17 [11/9/2023 4:27 PM] |
1.25 | -0.01 (-0.79%) |
1.34 | 0.08 (6.35%) |
0.92 - 7.80 | 337,071 | 650,000 | 3,729 | ||
| 09-08-2023 | PM | OMER | Omeros Corporation | 250.69 | -0.70 | -0.60 | -0.60 | Omeros GAAP EPS of -$0.70 misses by $0.13 [8/9/2023 8:04 AM] |
4.33 | 0.08 (1.76%) |
0.0 | 0.0 (0.00%) |
1.74 - 7.80 | 422,130 | 500,000 | 0 | ||
| 09-05-2023 | AH | 4:00 PM ET (May 9) |
OMER | Omeros Corporation | 321.68 | -0.63 | -0.55 | -0.56 | Omeros GAAP EPS of -$0.63 misses by $0.09 [5/9/2023 4:23 PM] |
6.09 | 1.09 (21.90%) |
5.00 | 0.0 (0.00%) |
1.74 - 7.75 | 810,204 | 430,000 | 6,163 | |
| 13-03-2023 | AH | 4:00 PM ET (Mar 13) |
OMER | Omeros Corporation | 255.94 | -0.73 | 0.00 | -0.37 | Omeros GAAP EPS of -$0.73 misses by $0.16 [3/13/2023 4:11 PM] |
3.82 | 0.37 (10.72%) |
3.46 | 0.01 (0.29%) |
1.74 - 7.75 | 673,415 | 320,000 | 8,362 | |
| 09-11-2022 | AH | 4:00 PM ET (Nov 9) |
OMER | Omeros Corporation | 205.75 | -0.87 | -0.61 | -0.26 | Omeros GAAP EPS of -$0.28 beats by $0.28 [11/9/2022 4:03 PM] |
2.66 | -0.16 (-5.67%) |
2.81 | -0.01 (-0.35%) |
1.86 - 8.60 | 671,965 | 300,000 | 2,434 | |
| 09-08-2022 | AH | 4:00 PM ET (Aug 9) |
OMER | Omeros Corporation | 246.53 | -0.60 | -0.68 | -0.40 | Omeros GAAP EPS of -$0.49 [8/9/2022 4:20 PM] |
7.48 | 1.28 (20.65%) |
6.60 | 0.40 (6.45%) |
1.85 - 16.57 | 1,419,199 | 740,000 | 2,618 | |
| 10-05-2022 | AH | 4:00 PM ET (May 10) |
OMER | Omeros Corporation | 185.04 | -0.56 | -0.74 | -0.50 | Omeros GAAP EPS of -$0.53 beats by $0.08 [5/10/2022 4:07 PM] |
2.61 | -0.11 (-4.04%) |
2.70 | -0.02 (-0.74%) |
2.60 - 18.86 | 1,115,765 | 870,000 | 500 | |
| 01-03-2022 | AH | 4:00 PM ET (Mar 1) |
OMER | Omeros Corporation | 449.68 | -0.37 | 0.91 | -0.54 | Omeros Non-GAAP EPS of -$0.37 misses by $0.31 [3/1/2022 4:04 PM] |
6.82 | -0.28 (-3.98%) |
6.80 | -0.30 (-4.23%) |
4.65 - 20.86 | 781,950 | 500,000 | 1,168 | |
|
||||||||||||||||||
| 09-08-2021 | AH | 4:00 PM ET (Aug 9) |
OMER | Omeros Corporation | 903.76 | -0.40 | -0.50 | -0.48 | 14.90 | 0.37 (2.55%) |
14.75 | 0.22 (1.51%) |
9.25 - 25.46 | 350,166 | 450,000 | 3,948 | ||
| 10-05-2021 | AH | 4:00 PM ET (May 10) |
OMER | Omeros Corporation | 1,110 | -0.50 | -0.51 | -0.41 | Omeros EPS misses by $0.06, beats on revenue [5/10/2021 4:05 PM] |
18.41 | 0.72 (4.07%) |
17.00 | -0.69 (-3.90%) |
9.25 - 25.46 | 504,221 | 510,000 | 5,591 | |
| 01-03-2021 | AH | 4:00 PM ET (Mar 1) |
OMER | Omeros Corporation | 1,450 | -0.54 | -0.64 | -0.21 | Omeros EPS beats by $0.09, misses on revenue [3/1/2021 4:03 PM] |
20.20 | 0.79 (4.07%) |
19.80 | 0.39 (2.01%) |
8.50 - 25.46 | 903,546 | 726,461 | 8,918 | |
| 09-11-2020 | AH | 4:00 PM ET (Nov 9) |
OMER | Omeros Corporation | 665.78 | -0.39 | -0.50 | -0.33 | Omeros EPS beats by $0.15, beats on revenue [11/9/2020 4:11 PM] |
11.07 | 0.08 (0.73%) |
11.25 | 0.26 (2.37%) |
8.50 - 25.46 | 903,076 | 592,908 | 247,498 | |
|
|
||||||||||||||||||